Updating the Canadian Hemophilia Outcomes–Kids’ Life Assessment Tool (CHO-KLAT) in the era of extended half-life clotting factor concentrates

Victoria E. Price, Saunya Dover, Victor S. Blanchette, Robert J. Klaassen, Mark Belletrutti, Aisha A.K. Bruce, Anthony K. Chan, Cindy Wakefield, Manuel Carcao, Vanessa Bouskill, Nancy L. Young

Résultat de recherche: Articleexamen par les pairs

5 Citations (Scopus)

Résumé

Introduction: The purpose of this study was to review and update the content of the Canadian Hemophilia Outcomes–Kids’ Life Assessment Tool version 2.0 (CHO-KLAT), in the context of extended half-life (EHL) factor concentrates (FCs) and to establish the validity and reliability of the updated CHO-KLAT. Methods: Focus groups were conducted with boys with hemophilia, their parents, and health care providers across Canada to review the CHO-KLAT v2.0 and determine if any modifications were required. The validity of the revised CHO-KLAT (version 3.0) was then determined in a sample of boys with hemophilia and their parents by calculating its correlation with the Pediatric Quality of Life Core Module (PedsQL-Core). Test-retest reliability was assessed using an intraclass correlation coefficient (ICC). Results: Thirteen focus groups at 5 pediatric hemophilia treatment centers (HTCs) (n = 71) resulted in 19 changes to the CHO-KLAT v2.0, generating a revised 40-item CHO-KLAT, the CHO-KLAT v3.0. Thirty-five boys with hemophilia (median age, 14; range, 7–17 years) and 47 parents participated in the validation of the CHO-KLAT v3.0. There was a moderate correlation between the CHO-KLAT v3.0 child self-report and PedsQL-Core (r = 0.56, P =.01), and a strong correlation between the CHO-KLAT v3.0 parent-proxy and PedsQL-Core (r =.79, P =.0007). The test-retest reliability ICC was 0.90 for the child self-report CHO-KLAT v3.0 and 0.68 for the parent-proxy CHO-KLAT v3.0. Conclusion: The CHO-KLAT v3.0 is a reliable and valid child-centric tool that effectively measures health-related quality of life in boys with hemophilia who are receiving standard half-life or EHL FCs.

Langue d'origineEnglish
Pages (de-à)403-411
Nombre de pages9
JournalResearch and Practice in Thrombosis and Haemostasis
Volume5
Numéro de publication3
DOI
Statut de publicationPublished - mars 2021

Note bibliographique

Publisher Copyright:
© 2021 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH)

ASJC Scopus Subject Areas

  • Hematology

PubMed: MeSH publication types

  • Journal Article

Empreinte numérique

Plonger dans les sujets de recherche 'Updating the Canadian Hemophilia Outcomes–Kids’ Life Assessment Tool (CHO-KLAT) in the era of extended half-life clotting factor concentrates'. Ensemble, ils forment une empreinte numérique unique.

Citer